Pro Medicus Limited (ASX: PME) Signs AUD $330M Contract with Trinity Health
Contract Overview
Pro Medicus Limited (ASX: PME) has announced the signing of a notable AUD $330M, 10-year contract with Trinity Health. The agreement involves the implementation of Visage 7, a cloud-based imaging platform designed to replace multiple legacy PACS throughout Trinity Health’s extensive network.
Implementation Details
The Visage 7 platform will be rolled out across Trinity Health, which encompasses 93 hospitals and numerous care locations across 26 states. The platform includes the Visage 7 Viewer, Visage 7 Open Archive, and Visage 7 Workflow and will migrate from the existing legacy systems operated by nine different vendors.
Executive Comments
Dr Sam Hupert, CEO of Pro Medicus, commented, “Trinity Health is our largest customer to date and the first with a national footprint. Our initiative with Trinity Health is noteworthy for its scope and scale which will see the Visage 7 platform used by over 650 Radiologists and thousands of clinicians who will benefit from the proven differentiation of Visage 7.” He added, “Our pipeline remains strong and spans all market segments.”
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.